Transcriptional analysis of the bovine herpesvirus 1 Cooper isolate. Temporal analysis and characterization of immediate-early, early, and late RNA.
Blot hybridization analysis of infected bovine herpesvirus 1 (BHV-1) cellular RNA isolated at various times post infection and after treatment with specific metabolic inhibitors was used to characterize transcription of the BHV-1 Cooper isolate. Synthesis of BHV-1 RNA was detected as early as 3 h post infection and reached a maximum at six to eight hours post infection. The most transcriptionally active area of the genome was between map units 0.110 to 0.195, within the HindIII I fragment. From the entire genome a total of 59 transcripts ranging in size from approximately 0.6 to 10 kilobases were characterized as belonging to one of three distinct classes. Using the protein synthesis inhibitor cycloheximide, three immediate-early transcripts were identified as originating from the internal inverted repeat region between map units 0.734 and 0.842, corresponding to the HindIII D fragment. Using phosphonoacetic acid to prevent virus DNA synthesis by inhibition of the BHV-1 DNA polymerase, 28 early transcripts were recognized. The remaining 28 transcripts, classified as late RNA, were detected without the use of metabolic inhibitors at 6 to 8 h post infection. Transcription of early and late RNA was not restricted to any specific area of the genome. Eighty percent of the transcripts from both the HindIII A fragment, between map units 0.381 to 0.537 within the unique long segment, and the HindIII K fragment, between map units 0.840 to 0.907 of the unique short segment, were designated as belonging to the early class.
Seal
B S
BS
Virology Cattle Research Unit, National Animal Disease Center, USDA, Ames, Iowa.
Irving
J M
JM
Whetstone
C A
CA
D000818:Animals; D015152:Blotting, Northern; D002417:Cattle; D002478:Cells, Cultured; D003001:Cloning, Molecular; D003513:Cycloheximide / Q000494:pharmacology; D004261:DNA Replication / Q000187:drug effects; D004279:DNA, Viral / Q000096:biosynthesis; D006564:Herpesviridae / Q000187:drug effects / Q000235:genetics*; D010746:Phosphonoacetic Acid / Q000494:pharmacology; D012367:RNA, Viral / Q000096:biosynthesis*; D015183:Restriction Mapping; D014158:Transcription, Genetic
D004279:DNA, Viral; D012367:RNA, Viral; D003513:Cycloheximide; D010746:Phosphonoacetic Acid